Streptolysin O inhibition of neutrophil chemotaxis and mobility: nonimmune phenomenon with species specificity.
The effects of streptolysin O (SO) (1 to 4 hemolytic units) on the mobility of neutrophilic leukocytes from humans, baboons, sheep, and rabbits were compared. After SO treatment, chemotaxis and random mobility of human neutrophils were markedly suppressed, baboon and sheep neutrophils were partially suppressed, and rabbit neutrophils were unaffected and demonstrated normal chemotaxis and mobility. The amounts of SO used in the mobility studies caused no leukocyte lysis or trypan blue uptake by human, baboon, or sheep cells, and minimal lysis or trypan blue uptake by rabbit cells. The possible involvement of immune mediators in the observed inhibition of human neutrophils was considered and excluded by the following studies. White blood cells from humans with humoral or cellular immune deficiencies responded in a manner similar to normal human cells; supernatant solutions from SO-treated human white blood cells did not contain a chemotactic suppressor; preincubation of SO with cholesterol (an inhibitor of SO hemolytic activity) caused loss of the chemotactic suppressive effect of the toxin on human leukocytes; and leukocytes from rabbits preimmunized with SO remained refractory to chemotactic suppression.
D000361:Agammaglobulinemia / Q000276:immunology; D000818:Animals; D002464:Cell Migration Inhibition; D002465:Cell Movement / Q000187:drug effects; D002633:Chemotaxis / Q000187:drug effects*; D002784:Cholesterol / Q000494:pharmacology; D002850:Chromatography, Gel; D004912:Erythrocytes / Q000187:drug effects; D000882:Haplorhini; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007108:Immune Tolerance; D007114:Immunization; D009504:Neutrophils / Q000187:drug effects*; D010215:Papio; D011817:Rabbits; D012756:Sheep; D012882:Skin Tests; D013045:Species Specificity; D013194:Staining and Labeling; D013297:Streptococcus pyogenes / Q000032:analysis; D013301:Streptolysins / Q000494:pharmacology* / Q000633:toxicity; D013997:Time Factors
D013301:Streptolysins; D002784:Cholesterol